IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—6 December

11:34 AM MST | December 6, 2012 | Deepti Ramesh

Cambrex appoints former Teva CEO as board vice chairman Cambrex (East Rutherford, NJ) says it has appointed Shlomo Yanai to its board of directors and will serve as its nonexecutive vice chairman. Yanai had been the president and CEO of Teva Pharmaceutical (PetaŠł• Tiqwa, Israel)—the largest generic pharmaceutical manufacturer in the world—until his retirement in mid-2012. As vice chairman of the Cambrex board, he will work closely with the company's other directors and its leadership team to formulate and help execute Cambrex's growth...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa